Propanc Biopharma Stock Number Of Shares Shorted
| PPCB Stock | USD 0.0002 0.0001 33.33% |
Propanc Biopharma fundamentals help investors to digest information that contributes to Propanc Biopharma's financial success or failures. It also enables traders to predict the movement of Propanc Pink Sheet. The fundamental analysis module provides a way to measure Propanc Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Propanc Biopharma pink sheet.
Propanc |
Propanc Biopharma Company Number Of Shares Shorted Analysis
Propanc Biopharma's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Propanc Biopharma has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Propanc Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Propanc Biopharma's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Propanc Biopharma could also be used in its relative valuation, which is a method of valuing Propanc Biopharma by comparing valuation metrics of similar companies.Propanc Biopharma is currently under evaluation in number of shares shorted category among its peers.
Propanc Fundamentals
| Return On Asset | -13.07 | |||
| Current Valuation | 1.53 M | |||
| Shares Outstanding | 1.76 B | |||
| Shares Owned By Insiders | 1.60 % | |||
| Price To Earning | (0.04) X | |||
| EBITDA | (2.14 M) | |||
| Net Income | (2.66 M) | |||
| Cash And Equivalents | 4.07 K | |||
| Total Debt | 1.1 M | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (1.44 M) | |||
| Earnings Per Share | (0.09) X | |||
| Target Price | 1.52 | |||
| Beta | 1.42 | |||
| Market Capitalization | 705.56 K | |||
| Total Asset | 81.65 K | |||
| Z Score | -85.8 | |||
| Net Asset | 81.65 K |
About Propanc Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Propanc Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Propanc Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Propanc Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Propanc Pink Sheet
Propanc Biopharma financial ratios help investors to determine whether Propanc Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Propanc with respect to the benefits of owning Propanc Biopharma security.